pcDNA-RELΔ9
(Plasmid
#27266)
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 27266 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1(-)
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5400
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameREL
-
SpeciesH. sapiens (human)
-
MutationDeletion of exon 9- aa 308-330; Y72H
-
Entrez GeneREL (a.k.a. C-Rel, HIVEN86A, IMD92)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XhoI (not destroyed)
- 3′ cloning site BamHI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer BGH-Rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please note that Addgene's sequencing results identified a Y72H mutation when compared to GenBank entry NP_002899.1. The depositing laboratory states that this mutation does not affect protein function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA-RELΔ9 was a gift from Thomas Gilmore (Addgene plasmid # 27266 ; http://n2t.net/addgene:27266 ; RRID:Addgene_27266) -
For your References section:
Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL. Leeman JR, Weniger MA, Barth TF, Gilmore TD. Oncogene. 2008 Dec 4. 27(53):6770-81. 10.1038/onc.2008.284 PubMed 18695674